Colon cancer blood test offers new screening option
Time:2024-05-21 19:38:11 Source:businessViews(143)
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Previous:Justin Timberlake set to bring his The Forget Tomorrow World Tour to Australia in 2025
Next:Hollywood star Shia LaBeouf is spotted on the streets of Gavin and Stacey's hometown Barry
You may also like
- Analysis: Larson enters conversation with Verstappen as best drivers in the world
- Amanda Holden puts on a VERY leggy display in a grey mini
- Victoria Beckham shows off her £300 mobility scooter while out with husband David
- Civil War viewers are left stunned by Jesse Plemons 'dead
- Devout Christian doctor, 68, who punched dementia
- Fiorentina fights back to draw with Genoa as both suffer from VAR decisions
- Man falls to death at oceanfront hotel trying to escape sixth
- EU agrees to open accession talks with Bosnia and Herzegovina
- Rangers are undefeated at .500 to keep World Series champs from a losing record with Bochy